Skip to content
1st Counsel – Lifestyle
Author:
DeGen Medical, Inc.
DeGen Medical Issues Statement on New CMS FY2027 Inpatient Classification for Patient-Specific Lumbar Fusion Procedures
August 25, 2026
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
August 19, 2026
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 17, 2026
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 22, 2026
DeGen Medical Expands Patient-Specific Spine Platform
May 18, 2026